
MS · NYSE
Expected to report Jan 14, 2027 — estimated from last year’s reporting date.
Consensus is $2.93 EPS for Dec 2026 across 7 estimates, ranging $2.72 to $3.11.
Morgan Stanley reported Q3 2026 diluted EPS of $3.03, beating the $2.83 consensus by 7.1%. EPS was 8% above the year-ago $2.80 but 12% below Q2’s $3.46. Net revenue of $20.34 billion rose 12% year over year and declined 5% sequentially; net income applicable to Morgan Stanley was $4.91 billion, up 6% year over year and down 12% from $5.58 billion in Q2. Firmwide return on average common equity was 17.8%, versus 18.0% a year ago and 20.7% in the prior quarter.
The quarter’s resilience came from Wealth Management, where revenue grew 10% year over year and net new assets reached $232.4 billion, supporting total client assets of $8.43 trillion. Institutional Securities remained substantially above last year, led by equity trading and advisory, but its revenue fell 9% from Q2 as trading and underwriting moderated. Investment Management was the weakest segment: revenue fell 12% year over year, including a swing to negative performance-based income. Expenses increased 12% year over year, broadly matching revenue growth, while the expense efficiency ratio was 67%. The $148 million credit-loss provision was higher than both the prior quarter and the year-ago period.
Firmwide non-interest expenses were $13.71 billion, down 1% sequentially but up 12% year over year, against net revenue growth of 12% year over year. The expense efficiency ratio was 67%, level with Q3 2025 and higher than 65% in Q2. Compensation and benefits were 39% of revenue, compared with 41% a year earlier. Return on average common equity was 17.8%, while return on average tangible common equity was 22.6%; both were below Q2’s 20.7% and 26.6%, respectively.